Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Biotech and Pharmaceuticals Biotechnology Health & Science
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Chevron Corp Breaking news AstraZeneca PLC
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags United Parcel Service Inc Whirlpool Corp Sherwin/Williams Co
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Business News Health care industry Companies
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Meta Platforms Inc Economy 5 Things to Know
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Companies Business News Science
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Science Biotech and Pharmaceuticals Policy
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Biotechnology Biotech and Pharmaceuticals Science
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags stocks Rivian Automotive Inc DraftKings Inc
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags stocks Markets Bloom Energy Corp
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Asia Markets World Markets Social issues
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Business News Policy Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Oracle Corp Royal Caribbean Cruises Ltd stocks
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags World News Health care industry Eisai Co Ltd
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Alzheimer's disease Health care industry US: News
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags U/S/ Markets Business Investment strategy
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Alzheimer's disease Health care industry Business
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Paycom Software Inc Cogent Communications Holdings Inc Breaking News: Markets
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags U/S/ Economy Business News Coronavirus
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags World News CVS Health Corp Eli Lilly and Co
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags Politics Business Social issues
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Eli Lilly and Co Business US: News
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Ionis Pharmaceuticals Inc US: News Health care industry
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Health care industry Breaking news Eli Lilly and Co
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Biotechnology Biotech and Pharmaceuticals Science
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Health care industry Breaking news Biotech and Pharmaceuticals
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags US: News Business Breaking news
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Policy Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags Business Eisai Co Ltd US: News
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags U/S/ Economy Business News Coronavirus
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.